Clinical Trial

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy

Study acronym: CENOTE
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will assess the safety, tolerability, and pharmacokinetics (PK) of intravitreal (IVT) injections of RO7663498 in participants with diabetic retinopathy (DR).
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-19
Trial Details
NCT Number NCT07588100
Lead Sponsor Hoffmann-La Roche
Conditions Diabetic Retinopathy
Enrollment 30 participants
Start Date 2026-06-18
Primary Completion 2027-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-20